GLP-1 receptor agonists have been shown in multiple studies to exert anti-inflammatory effects, including inhibition of monocyte chemotaxis, suppression of macrophage inflammatory responses, and AMPK-mediated downregulation of the NF-B signaling pathway, thereby reducing systemic inflammation (36)
This is why some media outlets and wellness podcasts have described retatrutide as a potential next step in obesity treatment
Risk is not determined by drug exposure alone
Because your digestion is slower, what you put into your stomach stays there much longer
Protecting your sleep is critical because sleep deprivation weakens your GLP-1 response to food
Serious Complications of Ozempic, Wegovy, Mounjaro and other GLP-1 Medications GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and others, have been linked to serious gastrointestinal illnesses and serious complications which may result in hospitalization or permanent injury